Efficacy and Toxicity of Docetaxel as a Radiosenstizer in Head and Neck Cancer
Clinical trial NCT06360978 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06360978
- Sponsor
- Assiut University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-01
- Primary completion
- 2025-06-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.